Last reviewed · How we verify

NCT04241757: EGG

Electrocardiogram in General Practice : the EGG Study

Terminated Last updated 22 June 2023
What this trial tests

trial testing ElectroCardioGram (ECG) in Indication for ElectroCardioGram in 888 participants. Terminated before completion.

Timeline
17 September 2019
Primary endpoint
1 October 2021
19 November 2021

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Saint Etienne
StatusTerminated
Study typeOBSERVATIONAL
Enrollment888
Start date17 September 2019
Primary completion1 October 2021
Estimated completion19 November 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Who can join

18 and older, any sex, with Indication for ElectroCardioGram. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Existing resources to assist interpretation of ElectroCardioGram (ECG) in general practice provide specialized and comprehensive reading based on pathologies and ElectroCardioGram (ECG) signs rather than ElectroCardioGram (ECG) indications. Describing practices in general medicine could help prioritize the relevance of clinical and ECG signs for the general practitioner, enabling to adjust the reading given the context.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Saint Etienne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04241757.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing